Evans, Patricia J.

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Jacobs, E. M. G., Hendriks, J. C. M., van Tits, B. L. J. H., Evans, P. J., Breuer, W., Liu, D. Y., Jansen, E. H. J. M., Jauhiainen, K., Sturm, B., Porter, J. B., et al. (2005) · Analytical Biochemistry

Iron Metabolism and DisordersClinical Laboratory Practices and Quality Control

Cited by 101

Inflammation and oxidant-stress in -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial

Walter, P. B., Macklin, E. A., Porter, J., Evans, P., Kwiatkowski, J. L., Neufeld, E. J., Coates, T., Giardina, P. J., Vichinsky, E., Olivieri, N., et al. (2008) · Haematologica

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 87

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait

Jones, E., Pasricha, S.-R., Allen, A., Evans, P., Fisher, C. A., Wray, K., Premawardhena, A., Bandara, D., Perera, A., Webster, C., et al. (2015) · Blood

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 68